Posted 1/3/2024, 10:45:18 PM
Pfizer Stock Stays Flat As Broader Markets Drop; Q4 Earnings Expected to Show Declines
- Pfizer (PFE) stock closed flat while broader markets sank
- Pfizer earnings expected on January 30, 2024, with projected 115.79% EPS decrease and 41.13% revenue decline year-over-year
- Recent Pfizer analyst estimate revisions reflect short-term business shifts and stock volatility
- Pfizer currently ranked as a Zacks Rank #5 (Strong Sell) stock
- Pfizer trades at a Forward P/E of 13.32, showing a discount vs industry average of 14.03